BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 21933664)

  • 1. Influence of the N-terminus and the E2-loop onto the binding kinetics of the antagonist mepyramine and the partial agonist phenoprodifen to H(1)R.
    Wittmann HJ; Seifert R; Strasser A
    Biochem Pharmacol; 2011 Dec; 82(12):1910-8. PubMed ID: 21933664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ligand-specific contribution of the N terminus and E2-loop to pharmacological properties of the histamine H1-receptor.
    Strasser A; Wittmann HJ; Seifert R
    J Pharmacol Exp Ther; 2008 Sep; 326(3):783-91. PubMed ID: 18577700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Probing ligand-specific histamine H1- and H2-receptor conformations with NG-acylated Imidazolylpropylguanidines.
    Xie SX; Ghorai P; Ye QZ; Buschauer A; Seifert R
    J Pharmacol Exp Ther; 2006 Apr; 317(1):139-46. PubMed ID: 16394198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological profile of histaprodifens at four recombinant histamine H1 receptor species isoforms.
    Strasser A; Striegl B; Wittmann HJ; Seifert R
    J Pharmacol Exp Ther; 2008 Jan; 324(1):60-71. PubMed ID: 17928567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular basis for the selective interaction of synthetic agonists with the human histamine H1-receptor compared with the guinea pig H1-receptor.
    Strasser A; Wittmann HJ; Kunze M; Elz S; Seifert R
    Mol Pharmacol; 2009 Mar; 75(3):454-65. PubMed ID: 19047480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of binding enthalpy and entropy to affinity of antagonist and agonist binding at human and guinea pig histamine H(1)-receptor.
    Wittmann HJ; Seifert R; Strasser A
    Mol Pharmacol; 2009 Jul; 76(1):25-37. PubMed ID: 19346300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions of histamine H1-receptor agonists and antagonists with the human histamine H4-receptor.
    Deml KF; Beermann S; Neumann D; Strasser A; Seifert R
    Mol Pharmacol; 2009 Nov; 76(5):1019-30. PubMed ID: 19720730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of impromidine- and arpromidine-derived guanidines on recombinant human and guinea pig histamine H1 and H2 receptors.
    Xie SX; Schalkhausser F; Ye QZ; Seifert R; Buschauer A
    Arch Pharm (Weinheim); 2007 Jan; 340(1):9-16. PubMed ID: 17206612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological differences between human and guinea pig histamine H1 receptors: Asn84 (2.61) as key residue within an additional binding pocket in the H1 receptor.
    Bruysters M; Jongejan A; Gillard M; van de Manakker F; Bakker RA; Chatelain P; Leurs R
    Mol Pharmacol; 2005 Apr; 67(4):1045-52. PubMed ID: 15626750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Constitutive activity and ligand selectivity of human, guinea pig, rat, and canine histamine H2 receptors.
    Preuss H; Ghorai P; Kraus A; Dove S; Buschauer A; Seifert R
    J Pharmacol Exp Ther; 2007 Jun; 321(3):983-95. PubMed ID: 17332265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations of Cys-17 and Ala-271 in the human histamine H2 receptor determine the species selectivity of guanidine-type agonists and increase constitutive activity.
    Preuss H; Ghorai P; Kraus A; Dove S; Buschauer A; Seifert R
    J Pharmacol Exp Ther; 2007 Jun; 321(3):975-82. PubMed ID: 17347323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N1-(3-cyclohexylbutanoyl)-N2-[3-(1H-imidazol-4-yl)propyl]guanidine (UR-AK57), a potent partial agonist for the human histamine H1- and H2-receptors.
    Xie SX; Kraus A; Ghorai P; Ye QZ; Elz S; Buschauer A; Seifert R
    J Pharmacol Exp Ther; 2006 Jun; 317(3):1262-8. PubMed ID: 16554355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Striking differences of action of lisuride stereoisomers at histamine H1 receptors.
    Pertz HH; Görnemann T; Schurad B; Seifert R; Strasser A
    Naunyn Schmiedebergs Arch Pharmacol; 2006 Dec; 374(3):215-22. PubMed ID: 17106670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple differences in agonist and antagonist pharmacology between human and guinea pig histamine H1-receptor.
    Seifert R; Wenzel-Seifert K; Burckstummer T; Pertz HH; Schunack W; Dove S; Buschauer A; Elz S
    J Pharmacol Exp Ther; 2003 Jun; 305(3):1104-15. PubMed ID: 12626648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temperature dependence of the binding of [3H]mepyramine and related compounds to the histamine H1 receptor.
    Wallace RM; Young JM
    Mol Pharmacol; 1983 Jan; 23(1):60-6. PubMed ID: 6135145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacology of [3H]-pyrilamine binding and of the histamine-induced inositol phosphates generation, intracellular Ca2+ -mobilization and cytokine release from human corneal epithelial cells.
    Sharif NA; Wiernas TK; Griffin BW; Davis TL
    Br J Pharmacol; 1998 Nov; 125(6):1336-44. PubMed ID: 9863665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homology modelling and binding site mapping of the human histamine H1 receptor.
    Kiss R; Kovári Z; Keseru GM
    Eur J Med Chem; 2004 Nov; 39(11):959-67. PubMed ID: 15501545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the second and third extracellular loops of the histamine H(4) receptor in receptor activation.
    Brunskole I; Strasser A; Seifert R; Buschauer A
    Naunyn Schmiedebergs Arch Pharmacol; 2011 Sep; 384(3):301-17. PubMed ID: 21800093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N(alpha)-imidazolylalkyl and pyridylalkyl derivatives of histaprodifen: synthesis and in vitro evaluation of highly potent histamine H(1)-receptor agonists.
    Menghin S; Pertz HH; Kramer K; Seifert R; Schunack W; Elz S
    J Med Chem; 2003 Dec; 46(25):5458-70. PubMed ID: 14640554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delineation of receptor-ligand interactions at the human histamine H1 receptor by a combined approach of site-directed mutagenesis and computational techniques - or - how to bind the H1 receptor.
    Jongejan A; Leurs R
    Arch Pharm (Weinheim); 2005 Jun; 338(5-6):248-59. PubMed ID: 15952243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.